Physician profile
Judith A Wolfe
NPI 1740507268
$719.06
in general payments reported to CMS, 2019-2025
9 companies · $96.91 in 2025
The $96.91 reported for 2025 was more than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $23.44 · 2023: $21.50 · 2024: $259 · 2025: $96.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $271.07 | 2021-2025 | Invos, Retia Medical, Mcgrath Mac |
| Pacira Pharmaceuticals Incorporated | $155.22 | 2021-2024 | Exparel |
| Acacia Pharma INC | $125.00 | 2021 | |
| Merck Sharp & Dohme LLC | $63.52 | 2021-2025 | Bridion |
| Lilly USA, LLC | $24.83 | 2024 | Omvoh |
| Vyaire Medical, INC. | $23.44 | 2022 | |
| Silk Road Medical, INC. | $21.50 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Takeda Pharmaceuticals U.S.A., INC. | $21.35 | 2025 | Gattex |
| Masimo Corporation | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.